Signal peptides are attracting attention for their potential to support smoother-looking skin. But are they really replacing retinoids? Here's what clinical research can—and can't—tell us.
For years, retinoids have been among the best-studied ingredients in skincare. They're known for helping improve the appearance of fine lines, uneven texture, and sun-related skin changes. Now, a different category is gaining attention: signal peptides.
You'll see them described as skin messengers, collagen-supporting ingredients, and sometimes even the next alternative to retinol. The science is interesting. But the idea that dermatologists are broadly replacing retinoids with peptides goes further than the evidence supports.
Here's what the research actually says—and how to make sense of it for your own routine.
First, what are signal peptides?
Peptides are short chains of amino acids. Certain cosmetic signal peptides are designed to resemble fragments of structural proteins or biological signals involved in skin maintenance.
One of the best-known examples is palmitoyl pentapeptide-4, also called Pal-KTTKS and commonly associated with Matrixyl. In laboratory research, related peptide signals have influenced fibroblasts—the cells involved in producing collagen and other components of the skin's supporting framework.
The idea is straightforward: instead of supplying a full collagen protein, a signal peptide may influence some of the processes associated with maintaining skin structure. But an interesting laboratory mechanism is not, by itself, proof that every peptide cream reaches those cells or rebuilds collagen in human skin. A review of cosmetic peptides explains both their potential and the challenges of getting them through the skin barrier.
What do human studies actually show?
1. A classic signal-peptide study showed modest improvement in fine lines
In a 12-week double-blind clinical trial, 93 women aged 35 to 55 used a moisturizer containing palmitoyl pentapeptide-4 on one side of the face and a control moisturizer on the other. Researchers reported a statistically significant improvement in certain wrinkle and fine-line measures with the peptide-containing product.
That's meaningful evidence for that peptide in that formula. It isn't evidence that every product labeled “peptide” will give identical results.
2. A 2025 study compared an experimental peptide with retinol
A 2025 randomized, double-blind clinical trial studied cyclized hexapeptide-9 (CHP-9), a specially designed experimental peptide. Ninety-six participants were randomized to use a serum containing 0.002% CHP-9, a serum containing 0.002% retinol, or a control serum for 56 days.
The peptide group performed better than the retinol comparator on several measurements of crow's feet and forehead wrinkles. That result is worth following.
The key detail: the retinol comparator was just 0.002%. The study did not establish that this peptide is superior to commonly used retinol strengths or prescription tretinoin. It also tested CHP-9 specifically—not signal peptides as a whole, and not any particular DOMI product. Larger independent trials are needed.
3. A 2026 review found promise, but also important limitations
A 2026 systematic review and meta-analysis combined 19 randomized controlled trials involving 1,341 people who used oral or topical peptide interventions.
The researchers found promising results for some skin-aging measures, including a modest overall effect on wrinkles. However, much of the wrinkle benefit was driven by oral peptides. Results for elasticity and skin density were inconsistent.
That matters because taking collagen peptides orally and applying a specific signal peptide to your face are different interventions. They should not be treated as interchangeable evidence.
So why aren't retinoids going anywhere?
Retinoids include several vitamin A-derived ingredients. Over-the-counter retinol and prescription tretinoin belong to the same broad family, but they aren't identical treatments.
Retinoids remain important because their effectiveness has been studied across many years. A 2024 systematic review of 25 comparative studies described tretinoin as the gold standard for treating photoaging and concluded that evidence was insufficient to support a new first-line replacement.
Another systematic review and meta-analysis of eight randomized trials found that tretinoin improved both fine and coarse wrinkles associated with sun damage.
The trade-off? Retinoids can cause dryness, peeling, irritation, and sensitivity, especially when someone starts too quickly or uses a formulation that doesn't suit their skin. The American Academy of Dermatology recommends choosing products based on individual skin concerns and tolerance.
Are peptides easier on sensitive skin?
Peptide-containing moisturizers can be appealing when the priority is hydration, comfort, and a simple routine. Many are formulated to feel gentler than stronger retinoid treatments, although sensitivity still depends on the full ingredient list.
For someone who cannot tolerate retinol, a well-formulated peptide moisturizer may be a reasonable skincare option. For someone already benefiting from retinol, peptides may fit alongside it rather than replace it.
There's another scientific limitation worth knowing: being smaller than collagen doesn't automatically mean a peptide can reach the dermis. Skin penetration depends on molecular size, charge, stability, and the delivery formula. That's why evidence for one peptide cannot automatically be transferred to another.
Where does DOMI fit into the conversation?
We believe skincare works best when you understand why you're using an ingredient—not just the trend around it.
DOMI's Retinol + Peptide Renewal Serum combines retinol and Hexapeptide-11 in a nighttime formula focused on smoother-looking texture and fine lines.
Our Peptide Barrier Moisturizer is a daily hydration-focused option for softer, more supple-looking skin. Its highlighted copper lysinate/prolinate and methylglucoside phosphate complex is not the same ingredient as Pal-KTTKS or the experimental CHP-9 studied above. Those research results should not be presented as clinical proof of the DOMI moisturizer's effects.
That distinction doesn't make a thoughtful skincare routine less worthwhile. It simply means ingredient-specific research matters—and so do the results you notice from a formula that's right for your skin.
Should you choose a signal peptide or a retinoid?
It doesn't have to be a competition.
- Consider a retinoid if you want an ingredient with an established body of research for photoaging and your skin tolerates it.
- Consider peptide-focused skincare if you want a supportive, hydration-oriented routine or a gentler-feeling complement to your existing products.
- Consider both thoughtfully if your skin tolerates them and your routine remains simple. More active ingredients don't always mean better results.
If you're new to retinol, introduce it gradually, moisturize, and use broad-spectrum SPF 30 or higher during the day. Avoid retinoids during pregnancy; consult your healthcare professional if you are pregnant, trying to conceive, or breastfeeding.
The real takeaway
Signal peptides deserve scientific attention. Some have encouraging laboratory findings, and a number of specific formulations have produced improvements in small human studies.
But “peptides are replacing retinoids” isn't a conclusion the research supports today.
The more useful question isn't which ingredient is winning. It's which routine makes sense for your skin.
At DOMI, that's the kind of skincare conversation we want to encourage: curious about the science, realistic about results, and focused on consistency rather than hype.
DOMI Skin — Skincare that grows with you.
Research and Sources
- Robinson et al. (2005) — Randomized trial of palmitoyl pentapeptide-4 in 93 women.
- Chang et al. (2025) — Randomized trial comparing CHP-9 with 0.002% retinol and vehicle.
- Nukaly et al. (2026) — Systematic review and meta-analysis of oral and topical peptide studies.
- Siddiqui et al. (2024) — Systematic review of tretinoin versus other topical treatments.
- Tretinoin for Photodamaged Facial Skin (2025) — Systematic review and meta-analysis of randomized trials.
- Peptides: Emerging Candidates for the Prevention and Treatment of Skin Senescence (2025) — Review of peptide mechanisms and delivery challenges.
This article is educational and is not personalized medical advice. Clinical research on individual ingredients does not establish that a particular finished DOMI product has been clinically tested for the same outcomes. Results vary by formulation and individual skin needs.